Valneva SE (XTER:AYJ) Beta: 1.8351 (As of Jun. 25, 2026)


XTER:AYJ Valneva SE XTER:AYJ
57 GF Score
Price €2.29
GF Value €2.48
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Valneva SE Beta?

Valneva SE XTER:AYJ -0.82% 57 Beta is 1.8351 as of Jun. 25, 2026. GuruFocus rates XTER:AYJ with a GF Score™ of 57/100 and a GF Value™ of €2.48 (Fairly Valued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Valneva SE's Beta is 1.8351.


Valneva SE  (XTER:AYJ) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Valneva SE Beta Related Terms


Valneva SE Beta Historical Data

* Premium members only.

The historical data trend for Valneva SE's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE Beta Chart

Valneva SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.35 -0.45 -1.27 1.27 0.00

Valneva SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 1.23 1.07 0.00 1.41

XTER:AYJ vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Valneva SE's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Beta distribution charts can be found below:

* The bar in red indicates where Valneva SE's Beta falls into.


XTER:AYJ
57GF Score
Valneva SE XTER:AYJ
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valneva SE Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.8351 mean?
Valneva SE (XTER:AYJ) has a Beta of 1.8351 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Valneva SE and its competitors.
Is Valneva SE's Beta too high?
Valneva SE's current Beta is 1.8351. Overall, Valneva SE has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Valneva SE's Beta compare to VRTX and REGN?
Valneva SE's Beta of 1.8351 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Valneva SE and its competitors. Valneva SE's current Beta is 1.8351. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valneva SE stock overvalued right now?
Based on GuruFocus' analysis, Valneva SE (XTER:AYJ) is currently considered Fairly Valued. The stock's GF Value™ is €2.48, compared to a current price of €2.29 — trading 7.5% below its estimated fair value. The current Beta is 1.8351. Valneva SE's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Valneva SE (XTER:AYJ), the current Beta is 1.8351 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valneva SE (XTER:AYJ) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of €2.29 is trading 7.5% below its estimated GF Value™ of €2.48. GuruFocus considers Valneva SE to be Fairly Valued.

Key valuation signals for XTER:AYJ:

  • Beta: 1.8351
  • GF Value™: €2.48 vs. price of €2.29 (7.5% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the XTER:AYJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
57GF Score

Get the complete analysis for XTER:AYJ

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.29
Price
€2.48
GF Value